- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-17-0000741

About Lozen Pharma Private Limited
Data last updated:
Lozen Pharma Private Limited is a private limited company based in Savanur, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2009PTC068381. Its GSTIN is 29AABCL5669C1ZD (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹37.55 Cr. It is led by directors including Arjun Gautam Ashra and Gautam Rasiklal Ashra.
Its last annual general meeting (AGM) was held on 25 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kssidc Industrial Estate Shiggaon Road, Savanur, Karnataka, India – 581118.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.38 Cr. For the same year it recorded a net profit of ₹1.05 Cr (net margin 2.2%) and EBITDA of ₹4.18 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 45% over five years.
The company has about 188 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lozen Pharma. As per MCA filings, the company has open charges of ₹13.98 Cr and satisfied charges of ₹1.45 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending.
Lozen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-17-0000741). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lozenpharma.com.
Company details
CIN history
Lozen Pharma has one previous CIN (Corporate Identification Number): U24239MH2009PTC189566. The current CIN is U24239KA2009PTC068381, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239KA2009PTC068381 | Current |
| U24239MH2009PTC189566 | Previous |
Recognitions & Rankings of Lozen Pharma
Contact details
Lozen Pharma Private Limited's registered office is in Savanur, Karnataka. Its website is lozenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKssidc Industrial Estate Shiggaon Road, Savanur, Karnataka, India – 581118
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lozen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lozen Pharma operates one associated brand: Lozen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medicated lozenges are manufactured by Lozen Pharma in Mumbai. | lozenpharma.com |
Business activity
The main business activities of Lozen Pharma are manufacturing and electricity, gas, steam and air condition supply. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and electric power generation, transmission and distribution. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| D | Electricity, gas, steam and air condition supply | D1 | Electric power generation, transmission and distribution |
To see the full business activity and turnover split of Lozen Pharma Private Limited, buy the company report.
Financials of Lozen Pharma Private Limited
FY 2025 filings availableLozen Pharma Private Limited reported revenue of ₹47.38 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lozen Pharma Private Limited, buy the company report.
Board of directors of Lozen Pharma Private Limited
Lozen Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Gautam Ashra | Director | 25 Oct 2016 | 10 Years 0 Months | Current |
| Gautam Rasiklal Ashra Also directs: Anassa Realty LLP, Multiples Private Equity Fund II LLP, Organic Biosystems LLP and 5 more | Director | 11 Aug 2023 | 3 Years 3 Months | Current |
| Jugal Parekh Also directs: Tibio Innovation Solutions Private Limited | Director | 27 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Lozen Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mendine Pharmaceuticals Pvt Ltd | ₹47.44 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Lozen Pharma Private Limitedthis company | ₹47.38 Cr (FY 2025) | ₹1.05 Cr | 2.2% | 188 | Savanur, Karnataka, India | |
| Sanctus Global Formulations Limited | ₹47.05 Cr (FY 2025) | 32.0% | Chandigarh, India | |||
| Navyug Pharma- Chem Pvt. Ltd. | ₹47.02 Cr (FY 2024) | -13.0% | Gujarat, India | |||
| Quantime World Private Limited | ₹47.01 Cr (FY 2025) | 79.0% | Pune, Maharashtra, India | |||
| Reliance Formulation Pvt Ltd | ₹46.68 Cr (FY 2023) | 4.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Lozen Pharma Private Limited, buy the company report.
Auditor
Lozen Pharma Private Limited is audited by M/s Manoj Ashra & Assiciates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s Manoj Ashra & Assiciates | FY 2022 | 106015W |
Shareholding
The shareholding of Lozen Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lozen Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2025 | 101159813 | Axis Bank Limited | ₹99.97 Lakh | Open | |
| 28 Apr 2025 | 101114684 | Others | ₹1.81 Cr | Open | |
| 21 Jun 2024 | 100953641 | Others | ₹11.17 Cr | Open | |
| 18 Aug 2016 | 100052284 | Others | ₹1 Cr | Satisfied | |
| 22 Dec 2011 | 10324535 | Karnataka State Financial Corporation | ₹45 Lakh | Satisfied |
To see the full charge records of Lozen Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Lozen Pharma Private Limited has 4 court cases on record: 1 filed by Lozen Pharma, 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 3 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed against the company by Bhadra Packaids Pvt Ltd | Disposed |
| High Court of Karnataka | Writ petition | Filed against the company by Clean Max Power Projects Private Limited | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against The Assistant Commissioner of Central Tax (CGST) | Pending |
| High Court of Karnataka | Appeal | Filed against the company by Karnataka Electricity Regulatory Commission | Pending |
To see the full case history of Lozen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lozen Pharma Private Limited has 8 MSME Form 1 returns on record between 2019 and 2023, listing 101 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sonarome Private Limited | |||
| Sheth Impression LLP | |||
| an individual supplier | |||
| an individual supplier | |||
| Translog Express Private Limited |
To see the full MSME payment records of Lozen Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lozen Pharma Private Limited has a workforce of 188 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 188 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Lozen Pharma Private Limited, buy the company report.
GST
Lozen Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCL5669C1ZD | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lozen Pharma Private Limited, buy the company report.
Recent activity
Lozen Pharma Private Limited has 9 board changes on record since 2016: 3 appointments and 6 cessations. The latest: Gautam Rasiklal Ashra ceased to be Additional Director on 28 Sep 2023.
8 earlier events are in the company report.
Frequently asked questions
Lozen Pharma is an active private limited company based in Savanur, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2009 (17+ years old) and is registered under CIN U24239KA2009PTC068381.
Lozen Pharma has 3 current directors:
- Arjun Gautam Ashra - Director
- Gautam Rasiklal Ashra - Director
- Jugal Parekh - Director
The latest financial statements of Lozen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 November 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lozen Pharma is 29AABCL5669C1ZD, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Lozen Pharma is U24239KA2009PTC068381. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lozen Pharma has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending.
Lozen Pharma was incorporated on 14 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Lozen Pharma by revenue are Mendine Pharmaceuticals Pvt Ltd, Sanctus Global Formulations Limited, Navyug Pharma- Chem Pvt. Ltd, Quantime World Private Limited, Reliance Formulation Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gautam Rasiklal Ashra ceased to be Additional Director on 28 Sep 2023. Gautam Rasiklal Ashra was appointed as Director on 11 Aug 2023. Gajanan Murlidhar Dixit ceased to be Director on 05 Feb 2021. Lozen Pharma has 9 board changes on record in total.
Yes, Lozen Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KR-17-0000741).
Lozen Pharma has 8 MSME Form 1 returns on record between 2019 and 2023, listing 101 overdue payments to 24 micro and small suppliers. The latest return was filed on 27 Apr 2023.
Lozen Pharma can be reached through the website lozenpharma.com. Its registered office is in Savanur, Karnataka, India.

